Discontinuation of Phoenix Active Ingredient Sales and Decline in Know-How Fee Income
First written in FY2017-Q1. 8 of 11 entries say "Restated". Latest entry: FY2021.
Nihon Nohyaku moved to the "Worse" side of this theme in 2021.
0 other companies' latest entry also says "Materialised".
- FY2021MaterialisedAnnual report
「Know-how royalty income declined because sales by the licensees struggled and other factors.」
The decline in know-how royalty income actually materialized in full-year performance due to sluggish sales by the licensees. - FY2020-Q1RestatedAnnual report
「Know-how royalty income exceeded the prior-year period because sales of the group's proprietary products by the licensees remained strong and other factors.」
Strong sales of the group's proprietary products by the licensees lifted know-how royalty income above the prior-year period. The previous downward pressure eased during the period. - FY2019-Q4MitigatedAnnual report
「Know-how royalty income exceeded the prior-year period because sales of the group's proprietary products by the licensees remained strong and other factors.」
Strong sales by the licensees eased the previous downward trend in know-how royalty income during the quarter. - FY2018RestatedAnnual report
「Know-how royalty income fell below the prior year because sales by the licensees struggled due to low pest incidence in their main sales regions and other factors.」
The disclosure again confirms a decline in know-how royalty income against a backdrop of low pest incidence in the licensees' main sales regions. - FY2019-Q1RestatedAnnual report
「Know-how royalty income fell below the prior-year period due to the impact of lower sales by the licensees resulting from low pest incidence and other factors in their main sales regions.」
The disclosure again confirms that know-how royalty income fell below the prior-year period against a backdrop of low pest incidence in the licensees' main sales regions and lower licensee sales. - FY2018-Q4RestatedAnnual report
「Know-how royalty income fell below the prior-year period because sales by the licensees struggled due to low pest incidence in their main sales regions and other factors.」
The disclosure again confirms that know-how royalty income struggled against a backdrop of low pest incidence in the licensees' main regions. - FY2017RestatedAnnual report
「Know-how royalty income fell below the prior year because sales by the licensees struggled due to low pest incidence in their main sales regions and other factors.」
The disclosure again confirms that know-how royalty income fell below the prior year against a backdrop of low pest incidence in the licensees' main regions. - FY2018-Q1RestatedAnnual report
「Know-how royalty income fell below the prior-year period because sales by the licensees struggled due to low pest incidence in their main sales regions and other factors.」
The disclosure again confirms that know-how royalty income struggled against a backdrop of low pest incidence in the licensees' main regions. - FY2017-Q4RestatedAnnual report
「Know-how royalty income struggled and fell below the prior-year period due to low pest incidence in the main sales regions of the licensees and other factors.」
The disclosure again confirms that know-how royalty income struggled against a backdrop of low pest incidence in the licensees' main regions. - FY2016RestatedAnnual report
「Sales totaled ¥50,641 million, down ¥6,288 million, or 11.0%, from the prior year, mainly because sales of Phoenix technical material to licensees ended in the previous fiscal year and know-how royalty income declined.」
The end of Phoenix technical-material sales and the decline in know-how royalty income are again cited as factors behind the full-year revenue decline. - FY2017-Q1First statedAnnual report
「Overseas agrochemical sales totaled ¥39,217 million, down ¥6,810 million, or 14.8%, from the same quarter of the prior year, mainly because sales of Phoenix technical material to licensees ended in the previous fiscal year and know-how royalty income declined substantially.」
The end of sales to licensees and the decline in royalty income are cited as factors behind the 14.8% year-on-year revenue decline.